All Pediatric Transplantation Articles
Export Citations
Download PDFs
-
mTor-inhibition within the first days after pediatric heart transplantation is a potentially safe option to prevent cardiac allograft vasculopathyoa
Graphical Abstract
Initiating Everolimus therapy early after pediatric HTX seems to be a safe and effective option for immunosuppression, with no incidence of cardiac allograft vasculopathy and a low incidence in chronic renal failure.
-
Changes in graft outcomes in recipients <10 kg over 25 years of pediatric kidney transplantation in the United Statesoa
Graphical Abstract
The impact of weight at the time of kidney transplantation and how pediatric kidney transplant outcomes have changed over 25-years for recipients weighing <10 kg.